Outpatient Surgery Magazine - Subscribers

Comfy ORs - June 2014 - Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://outpatientsurgery.uberflip.com/i/329643

Contents of this Issue

Navigation

Page 106 of 170

THE TRUTH HURTS PACIRA'S CLAIM: EXPAREL ® provides patient-focused pain control for up to 72 hours. 3 THE FACTS: Based on further analysis of the data, 6 between 12–72 hours there was minimal to no difference in mean pain intensity between EXPAREL ® and saline (placebo). 4-5 PACIRA'S CLAIM: The only single-dose local analgesic to reduce or eliminate opioids with pain control for up to three days. 3 THE FACTS: The clinical benefi t of the attendant decrease in opioid consumption was not demonstrated. 2-3 Saline therapy (placebo) was favored between 12–72 hours. 5 Get the facts and download studies about EXPAREL ® at factvsfi ction.info or call 1-800-448-3569 for more information. The truth behind EXPAREL ® (bupivacaine liposome injectable suspension) 1 What is EXPAREL®, EXPAREL® Website. www.exparel.com/what-is-exparel.shtml. Created May 2, 2008. Updated December 16, 2013. Accessed February 4, 2014. 2 Exparel® [prescribing information]. Parsippany, NJ: Pacira Pharmaceuticals, Inc.; 2011. 3 EXPAREL. Advertisement. Outpatient Surgery1 Nov. 2013:57-58. Print. 4 Golf M, Daniels SE, Onel E. A Phase III, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther. Sep 2011;28(9):776-788. 5 Gorfi ne SR, Onel E, Patou G, et al. Bupivacaine Extended-Release Liposome Injection for Prolonged Postsurgical Analgesia in Patients Undergoing Hemorrhoidectomy: A Multicenter, Randomized, Double-blind, Placebo-controlled trial. Dis Colon Rectum. Dec. 2011;54(12):1552-1559. 6 Data on File. EXPAREL® is a registered trademark of Pacira Pharmaceuticals Inc. I-Flow*, LLC, A Kimberly-Clark Health Care Company. ON-Q* Pain Relief System *Registered trademark or trademark of Kimberly-Clark Worldwide Inc. © 2014 KCWW All rights reserved. RX Only. MK-00652 Effective post-op pain management. For over 3.5 million patients and counting. Controllable. Long-lasting. Proven. 6 Promotional claims position EXPAREL ® as the only single-dose local analgesic to reduce or eliminate opioids with pain control for up to three days with no need for catheters or pumps. 1-2 Sound too good to be true? It is. Every day without costs you more 6 Every day without costs you more A K I M B E R L Y - C L A R K H E A L T H C A R E C O M P A N Y OSE_1406_part2_Layout 1 6/13/14 11:41 AM Page 107

Articles in this issue

Links on this page

Archives of this issue

view archives of Outpatient Surgery Magazine - Subscribers - Comfy ORs - June 2014 - Outpatient Surgery Magazine